| Lot Release Number |
2020-06-05-0155
|
| FDA Registered Product/Generic Name |
Omalizumab
|
| Brand Name |
Xolair
|
| Dosage Strength |
202.5 mg
|
| Dosage Form |
Lyophilized Powder for Injection (S.C.)
|
| Registration Number |
BR-987
|
| Batch/Lot Number |
SWA60
|
| Packaging Lot |
Packaging Lot (box and vial): SWA60;
Diluent: 11580832
|
| Product Expiration Date |
30 September 2023
|
| Issuance Date |
10 June 2020
|